Optinose to Present at the 2018 Cantor Global Healthcare Conference

YARDLEY, Pa., Sept. 24, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present at the 2018 Cantor Global Healthcare Conference October 1, 2018, at 10:05 a.m. ET. To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website. A replay of the webcast will be available for 30 days following the conclusion of the event.

About Optinose Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. Optinose has offices in the U.S., the U.K. and Norway. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.  

Optinose Investor ContactJonathan Neely[email protected]267.521.0531

You May Also Be Interested In

• CDT Equity Inc. Announces Reverse Stock Split
• CoinMarketCap Acquires Coinglass, Bringing Crypto Derivatives Data to the World's Most-Referenced Crypto Price Tracker
• Karbon-X (OTCQB:KARX) to Present Global Growth Strategy and Showcase SkyXero at 26th MK-Equity Investment Conference in Munich